Vanguard Group Inc Pasithea Therapeutics Corp. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.31 - $0.5 $12,148 - $19,594	-39,188 Reduced 24.46%	121,007 $59,000
Q4 2022 Feb 10, 2023	BUY	$0.55 - $26.0 $193 - $9,126	351 Added 0.22%	160,195 $102,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $26.4 $6,536 - $2.16 Million	81,705 Added 104.56%	159,844 $201,000
Q2 2022 Aug 12, 2022	BUY	$16.52 - $27.0 $356,105 - $582,012	21,556 Added 38.1%	78,139 $79,000
Q1 2022 May 13, 2022	BUY	$19.4 - $35.8 $851,330 - $1.57 Million	43,883 Added 345.54%	56,583 $74,000
Q4 2021 Feb 14, 2022	BUY	$28.8 - $112.0 $365,760 - $1.42 Million	12,700 New	12,700 $22,000

Ticker KTTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,398,700
Market Cap $157M
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.